Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lovastatin-induced acute cholestatic hepatitis]

H Huchzermeyer1, R Münzenmaier

  • 1Medizinische Klinik, Klinikum Minden.

Deutsche Medizinische Wochenschrift (1946)
|February 24, 1995
PubMed
Summary

Lovastatin, a cholesterol-synthesis inhibitor, can cause acute cholestatic hepatitis in patients. Discontinuation of lovastatin led to slow recovery of liver function in two cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Whipple's disease: typical cases and review].

MMW Fortschritte der Medizin·2005
Same author

[Surprising findings in the colon 15 years after a holiday in Africa].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

[Duodenal ileus due to an intramural duodenal haematoma. Conservative therapy using a multiple lumen intestinal probe].

Deutsche medizinische Wochenschrift (1946)·2005
Same author

[Gastrointestinal stromal tumours (GIST) of the jejunum in a patient with neurofibromatosis type 1 (von Recklingshausen's disease)].

Zeitschrift fur Gastroenterologie·2004
Same author

[Multiple focal liver lesions of a 33 year-old female. Presentation of an unexpected differential diagnosis].

Der Internist·2004
Same author

Retrieval of a dislocated plastic stent from the ductus hepaticus Dexter using a new balloon system.

Zeitschrift fur Gastroenterologie·2004

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Hypercholesterolemia is a common condition requiring pharmacological intervention.
  • Statins, such as lovastatin, are widely prescribed cholesterol-synthesis inhibitors.
  • Drug-induced liver injury (DILI) is a significant concern in pharmacotherapy.

Observation:

  • Two patients developed acute cholestatic hepatitis after prolonged lovastatin treatment.
  • Symptoms included fatigue, loss of appetite, jaundice, colorless stool, and dark urine.
  • Significant elevations in alkaline phosphatase and gamma-GT, along with elevated transaminases, were noted.

Findings:

  • Liver biopsy findings were consistent with drug-toxic liver damage.
  • Other potential causes of hepatitis were ruled out.
  • Cholestasis parameters showed slow regression after lovastatin discontinuation.

Implications:

  • Lovastatin can induce acute cholestatic hepatitis, even after long-term use.
  • Close monitoring for liver dysfunction is crucial in patients on lovastatin.
  • Early recognition and drug withdrawal are essential for managing lovastatin-induced hepatotoxicity.

Related Experiment Videos